Since NS19504 treatment promoted the outcome of stroke, we detected whether inflammation affects the significant difference between groups, and the mRNA levels of inflammation factors TNF-α, IL-1β, IL-6, IL-10, and TGF-β were examined. This evidence concerns the gene IL6 and Stroke.